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Cap-dependent translation initiation is regulated
by the interaction of eukaryotic initiation factor 4E
(eIF4E) with eIF4E binding proteins (4E-BPs).
Whereas the binding of 4E-BP peptides containing
the eIF4E-binding 54YXXXXLF60 motif has been
studied, atomic-level characterization of the interac-
tion of eIF4E with full-length 4E-BPs has been lack-
ing. Here, we use isothermal titration calorimetry
and nuclear magnetic resonance spectroscopy to
characterize the dynamic, structural and binding
properties of 4E-BP2. Although disordered, 4E-BP2
contains significant fluctuating secondary structure
and binds eIF4E at an extensive bipartite interface
including the canonical 54YXXXXLF60 and 78IPGVT82
sites. Each of the two binding elements individually
has submicromolar affinity and exchange on and
off of the eIF4E surface within the context of the
overall nanomolar complex. This dynamic inter-
action facilitates exposure of regulatory phos-
phorylation sites within the complex. The 4E-BP2
interface on eIF4E overlaps yet is more extensive
than the eIF4G:eIF4E interface, suggesting that these
key interactions may be differentially targeted for
therapeutics.
INTRODUCTION
Recruitment of the 40S ribosome to mRNA by the eukaryotic
initiation factor 4F (eIF4F) complex is a critical control point in
translation initiation in eukaryotes (Sonenberg and Hinnebusch,
2009). The eIF4F complex includes eIF4E, which binds to
the mRNA 50 cap structure, 7-methylguanosine triphosphate
(m7GpppN, where N is any nucleotide), eIF4A, an RNA helicase,
and eIF4G, a scaffolding protein. Under most physiological con-
ditions, availability of eIF4E is rate-limiting and, as such, the ac-
tivity of eIF4E is an important target for translational control
(Gingras et al., 1999a).
The activity of eIF4E is regulated by eIF4E binding proteins
(4E-BPs), of which there are three known mammalian isoforms:2186 Structure 21, 2186–2196, December 3, 2013 ª2013 Elsevier Ltd4E-BP1, 4E-BP2, and 4E-BP3. 4E-BPs and eIF4G share a
YXXXXLF eIF4E-binding motif and an overlapping binding sur-
face on eIF4E, such that 4E-BP binding to eIF4E sterically blocks
binding of eIF4G, preventing assembly of eIF4F (Mader et al.,
1995;Marcotrigiano et al., 1999). The 4E-BPs play essential roles
in development and cell growth in all cell types and, in neurons,
4E-BP2 is critical for synaptic plasticity, learning and memory
formation (Banko et al., 2007), as well as in autism spectrum dis-
orders (Gkogkas et al., 2013; Santini et al., 2013). Unphosphory-
lated or minimally phosphorylated 4E-BPs associate tightly with
eIF4E to inhibit cap-dependent translation, whereas highly phos-
phorylated 4E-BPs dissociate from eIF4E, allowing translation to
proceed. Among other kinases, the mammalian target of rapa-
mycin (mTOR) phosphorylates 4E-BPs using the adaptor protein
Raptor (Hara et al., 2002). A hierarchical phosphorylation model
of 4E-BPs has been described in which T37 and T46 are phos-
phorylated first followed by T70 and S65 (Gingras et al.,
1999b). Because of the tight interaction of the eIF4E:4E-BPs
complex, low koff rates (1.2–3.7 3 104/s) of 4E-BP2 and the
fact that 4E-BP2 is in excess in vivo, 4E-BP2 phosphorylation
likely occurs on the complex and phosphorylation sites must
be accessible to large kinases in the bound state in order to
enable the rapid biological response. This is because if phos-
phorylation occurs on the free state, then all the excess 4E-
BP2 has to be phosphorylated first before phosphorylation will
have any effect on complex formation. Importantly, it has been
previously shown that some kinases can phosphorylate 4E-
BPs both in the absence and presence of eIF4E (Gingras et al.,
1999b; Lawrence et al., 1997). Understanding the molecular
mechanism of eIF4E and 4E-BP interaction is crucial because in-
hibiting 4E-BP phosphorylation or designing 4E-BP mimics may
be useful in suppressing tumors. Indeed, a number of potential
anticancer drugs target the eIFE:4E-BP complex or its phos-
pho-regulation (Bjornsti and Houghton, 2004; Faivre et al.,
2006; Jia et al., 2012).
Because of the crucial role of eIF4E in cellular homeostasis
and pathologies, the structure of eIF4E has been studied in detail
with and without different cap analogs (Volpon et al., 2006; Von
der Haar et al., 2004). The first 37 residues of eIF4E are disor-
dered whereas the rest of the protein consists of a conserved
fold in the shape of a glove (Figure 1). The mRNA cap-binding
site is located on the concave surface of eIF4E. 4E-BPs,
eIF4G, and other eIF4E interacting proteins bind the convex sur-
face of eIF4E and modulate the cap-binding properties of eIF4EAll rights reserved
Figure 1. Crystal Structure of eIF4E in Complex with a Pro47-Thr70
4E-BP2 Peptide and m7GTP cap
Pro47-Thr70 4E-BP2 peptide (red) and m7GTP cap (stick model; Protein Data
Bank [PDB] code 3AM7; Fukuyo et al., 2011). b strands (b), a helices (a), loops
(L), and residues critical in cap binding are labeled. Note that residues Pro66-
Thr70 of 4E-BP2 and the intrinsically disordered Met1-Gln26 of eIF4E are not
visible in the electron density map. The cap is shown for orientation purposes
only because most experiments were performed in the absence of the cap.
Structure
Structure and Binding of 4E-BP2(Moerke et al., 2007; Topisirovic and Borden, 2005; Volpon et al.,
2006). Using X-ray crystallography, nuclear magnetic resonance
(NMR), and other biophysical tools, a number of structural and
thermodynamic studies have characterized the eIF4E interac-
tion with 20-residue peptides containing the canonical
54YXXXXLF60 binding motif of 4E-BPs (Figure 1). This motif is
also present in other eIF4E binding proteins such as Cup, Gemin,
and 4E-T (Dostie et al., 2000; Mader et al., 1995; Rhoads, 2009).
However, previous NMR experiments and more recent dele-
tion studies have shown that the binding of peptides containing
the canonical binding site differs significantly from that of full-
length 4E-BPs. Wagner and colleagues showed that these pep-
tides do not reproduce all of the NMR spectral changes induced
on eIF4E by full-length 4E-BP1 (Fletcher et al., 1998). Later, Ish-
ida and colleagues used systematic deletion mutagenesis and
surface plasmon resonance to demonstrate that the residues
C-terminal to the canonical binding site contribute significantly
to binding with the affinity of full-length 4E-BPs being approxi-Structure 21, 2186–21mately two to three orders of magnitude higher than those of
the peptides (Abiko et al., 2007). Note that a range of dissociation
constants (KDs) for peptides has been reported in the literature
where different lengths of peptides and/or cap analogs were
used (Marcotrigiano et al., 1999; Niedzwiecka et al., 2002; Tait
et al., 2010), but the most recent measurements show micro-
molar KDs, while binding of full-length 4E-BPs is nanomolar
(Paku et al., 2012; Umenaga et al., 2011). In addition, NMR
studies show that these peptides undergo a disorder-to-order
transition upon binding eIF4E, with both the free and bound res-
onances being observed (Tait et al., 2010). In contrast, full-length
4E-BPs show very minimal chemical shift changes and signifi-
cant loss of peak intensity for many of the residues without
observation of the bound resonances (Fletcher et al., 1998).
The absence of NMR resonances for the bound state of residues
in the binding interface can be due to a number of factors
including the more rapid relaxation rates caused by the signifi-
cantly increased molecular weight from the free to the bound
state (13 kDa to 38 kDa) that slows the rotational correlation
time for tumbling (tc) and/or chemical exchange in which these
residues dynamically sample two or more states on the interme-
diate NMR timescale (see Results). The striking differences
between the NMR spectra of complexes with peptides and
with full-length 4E-BPs suggest that a dynamic/fuzzy complex
is formed, resulting in an ensemble of conformations being
sampled in the bound state (Fuxreiter and Tompa, 2012).
Whereas low-resolution small-angle X-ray scattering (SAXS)
models (envelope) for free full-length 4E-BP and in complex
with eIF4E were recently generated (Gosselin et al., 2011), no
detailed atomic-level structural and dynamic studies of any
apo full-length 4E-BP or in complex with eIF4E in the absence
of an mRNA cap have been performed. Previous characteriza-
tion of full-length 4E-BP1 and its interaction with eIF4E was hin-
dered by the lack of complete NMR chemical shifts assignments
at key binding interface residues and the absence of the bound
resonances for the complex (Fletcher et al., 1998; Fletcher and
Wagner, 1998). Since then, state-of-the-art NMR methods de-
signed for intrinsically disordered proteins or regions (IDPs/
IDRs) have been developed (Marsh and Forman-Kay, 2011; Me-
ier et al., 2008; Schneider et al., 2012). IDPs/IDRs such as the 4E-
BPs and the N-terminal region of eIF4E lack stable secondary
and tertiary structure, yet are increasingly recognized for the crit-
ical biological roles they play in mediating regulatory protein
interactions, particularly those involving posttranslational modi-
fications such as phosphorylation (Dyson and Wright, 2005; Xie
et al., 2007). IDPs augment the structure/function paradigm by
utilizing disorder and dynamic interactions, rather than well-
defined structures, to mediate biological function. Although
many IDPs undergo a disorder-to-order transition upon interact-
ing with their binding partners, some IDPs maintain a significant
degree of disorder even in their bound states (Fuxreiter and
Tompa, 2012; Mittag et al., 2010). Detailed structural character-
izations of IDPs and their dynamic complexes are highly chal-
lenging due to the inapplicability of X-ray crystallography as
well as the poorly resolved NMR chemical shifts and resonance
broadening due to tc and chemical exchange effects. Nonethe-
less, recent developments in NMR spectroscopymake this tech-
nique the most powerful tool to characterize the structural and
dynamic properties of IDPs and their complexes.96, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2187
Figure 2. Assignment of Full-Length
4E-BP2
HSQC spectrum of 4E-BP2 at 5C. Residues with
multiple conformations are labeled with and
without an apostrophe (’) for the minor and major
states, respectively. Peaks from the eight-residue
tag are labeled from 1 to 8. Because of the
multiple sequence repeats, some peaks could not
be assigned with certainty and are left unlabeled.
See also Figure S1.
Structure
Structure and Binding of 4E-BP2In this work, we characterize the atomic level dynamic and
structural properties of full-length 4E-BP2 as well as investigate
its binding mechanism to eIF4E. Our results show that, whereas
free 4E-BP2 is intrinsically disordered, it possesses significant
transient secondary structure throughout the protein with a
high helical propensity in the canonical binding site. We also
observe that 4E-BP2 binds to eIF4E using a bipartite mode
of interaction involving residues spanning from immediately
N-terminal to the canonical binding site to beyond the
highly conserved 78IPGVT82 sequence. Interestingly, mutating
78IPGVT82, but not 54YXXXXLF60, significantly changes the
dynamics of the complex such that some previously invisible
resonances of the bound state can be observed. Furthermore,
our isothermal titration calorimetry (ITC) studies show that
the binding of the canonical site is enthalpically driven,
whereas interaction of the secondary binding site is driven by
entropy, suggesting that this second site is highly dynamic in
the complex. The dynamic nature of 4E-BP2 was observed
in complexes with both cap-free and cap-bound eIF4E.
Finally, by monitoring the effects of full-length 4E-BP2 binding
on eIF4E, we observed significant resonance broadening on
the surface of eIF4E and chemical shift changes throughout2188 Structure 21, 2186–2196, December 3, 2013 ª2013 Elsevier Ltd All rights reservedeIF4E, demonstrating extensive allosteric
effects of 4E-BP binding. Our data
provide key insights into the structural
and dynamic properties of 4E-BPs
and their mechanism of interaction
with eIF4E as well as their competition
with eIF4G and regulation by multisite
phosphorylation.
RESULTS
4E-BP2 Is Intrinsically Disordered,
yet Contains Significant Secondary
Structural Propensities
We used a combination of standard NMR
assignment experiments and those spe-
cifically designed for IDPs and glycine/
proline-rich proteins to assign the full-
length free 4E-BP2. Figure 2 is a 2D
1H-15N HSQC of 4E-BP2 showing many
sharp peaks and a narrow amide 1H
chemical shift dispersion, both charac-
teristic signatures of IDPs (Dyson and
Wright, 2001). While there are only 118
non-proline residues for this 4E-BP2construct, 195 peaks with a high degree of differential peak
intensities were found. The majority of the additional peaks
and the peaks for residues R20 to R63 are relatively weak in
intensity (Figure S1 available online), likely due to chemical ex-
change that is slow to intermediate-slow on the NMR timescale
(see the Discussion on the NMR timescale and chemical ex-
change). Some of these additional peaks originate from cis/
trans isomerization of the multiple proline residues, while others
are not due to proline isomerization and must arise due
to conformational exchange within the 4E-BP2 disordered
ensemble. For example, residues T41 and T50 possess multiple
weak and overlapping peaks. However, not all of these addi-
tional peaks could be assigned with certainty due to the
presence of multiple sequence repeats within 4E-BP2 (i.e.,
36TTPGGT41 and 45TTPGGT50). Ninety-nine percent of the HN,
N, C0, Ca, and Cb assignments and 87% of Ha assignments
were obtained for the major conformation.
Ca, Cb, and Ha chemical shifts were used to quantify transient
secondary structure in free 4E-BP2 using the Secondary Struc-
ture Propensity (SSP) program (Marsh et al., 2006), with SSP
values of +1 and 1 expected for fully formed helices and
extended regions, respectively. Figure 3A shows SSP values
Figure 3. Transient Secondary Structure,
Relaxation Properties, and Binding Inter-
face of 4E-BP2
(A) SSP values.
(B) R2 relaxation rate constants with error bars
representing SD.
(C) 1H-15N NOE values.
(D) Resonance intensity ratios for TROSY-HNCO
peaks of eIF4E-bound and apo 4E-BP2 showing
significant loss of intensity in the canonical binding
site (G40-P66) and secondary binding site (H74-
D90). Proline residues or residues that precede
prolines for which no data were obtained are
indicated by negative values in Figures 3B, 3C,
and 3D.
See also Figure S2.
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Structure and Binding of 4E-BP2of free 4E-BP2, indicating that, while 4E-BP2 is intrinsically
disordered in its free state, it contains significant transient
secondary structure. Five regions, M1-A5, D33-T37, T50-N64,
T86-E89, and N96-D105, have helical propensities greater than
0.15. The residues with the highest helical propensities (up to
0.37) are located within the canonical eIF4E-binding region
and are flanked by regions with a high fraction (up to 0.27)Structure 21, 2186–2196, December 3, 2013 ªof fluctuating extended conformations.
Other regions with high degrees of tran-
sient structure include segments outside
of the canonical binding site that form
part of the eIF4E-binding interface (see
below).
Next, we investigated the dynamic
properties of free 4E-BP2 by measuring
15N relaxation rates. Low R2 relaxation
rate constants are expected for a
completely disordered protein with no
long-range contacts and rapid motions
on the picosecond to nanosecond time-
scales, whereas high rates indicate
slower interconversion between confor-
mations on the microsecond to milli-
second timescale (Schwalbe et al.,
1997). The R2 relaxation rate constants
of free 4E-BP2 are not low (Fig-
ure 3B), with the highest R2 rates
corresponding to regions with the high-
est transient secondary structure as
assessed by the SSP values. The heter-
onuclear NOE values for 4E-BP2 (Fig-
ure 3C), which are sensitive to local
motions, are relatively high (up to
0.7), indicating significant transient
secondary structure or tertiary contacts
within the protein. This is in contrast
to expectations for IDPs of heteronu-
clear NOE values significantly lower
than 0.8 and even negative. Taken
together, these data suggest that free
4E-BP2 contains significant transient
secondary structure and restricted mo-tions with contributions from conformational exchange within
the disordered ensemble.
4E-BP2 Binding to eIF4E Is Dynamic and Involves a
Bipartite Binding Region
The effect of ligand binding on the NMR spectra depends on
the relaxation effects resulting from increase in molecular weight2013 Elsevier Ltd All rights reserved 2189
Figure 4. The Interaction of 15N,13C 4E-BP2
with Unlabeled eIF4E
1H-15N HNCO projection of 4E-BP2 with 0 (red),
0.2 (orange), 0.6 (green), and 1.4 (blue) molar ratios
of eIF4E, showing significant spectral changes in
the presence of increasing amounts of eIF4E
at 5C. Labeled are selected residues from both
the canonical and secondary binding sites un-
dergoing complete and partial loss of peak in-
tensity.
See also Figures S2–S4.
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Structure and Binding of 4E-BP2(tc effects) as well as chemical exchange. The latter reflects the
difference between the free and bound state resonance fre-
quencies (Du) compared to the exchange rates (kex) for binding
(Rule and Hitchens, 2006). If kex < Du, the exchange is slow on
the NMR timescale and two peaks are expected, for free and
bound states, with their population proportional to their inte-
grated intensities. For fast exchange, kex > Du, a single peak is
observed at the population weighted average of the free and
bound chemical shifts and resonances migrate from the free
to bound state positions as ligand concentration is increased.
If kex Du, intermediate exchange occurs, accompanied by
broadening of peaks which also migrate from free to bound state
positions with added ligand. If the bound state itself is dynamic
with additional conformational exchange, the effects can be
more complex. Therefore, binding can give rise to a range of
chemical exchange behaviors depending on individual chemical
shift changes and exchange rates.
To map the binding interface on 4E-BP2, we analyzed
changes in peak intensities, chemical shifts and linewidths using
TROSY-HNCO experiments (for better chemical shift resolution)
for 15N,13C-labeled 4E-BP2 in the absence and presence
of increasing amounts of unlabeled eIF4E. When increasing
amounts of eIF4E were added to 4E-BP2, minimal migration of
peaks was observed (Figure 4) and line widths of free 4E-BP2
were relatively constant for most residues (Figure S2). However,
there were significant changes in peak intensities. This is consis-
tent with resonances of free 4E-BP2 that have large chemical
shift changes upon binding being in slow exchange with those
of the bound 4E-BP2 as expected for such a tight, nanomolar
KD interaction. The slow exchange between free and bound
states for most residues at the interaction interface leads to
loss of free state resonances yet the bound state resonances
are not observable, likely due to a combination of slower tum-
bling in a larger complex (tc effect) and conformational exchange
broadening within the bound state. Figure 3D plots the ratio of2190 Structure 21, 2186–2196, December 3, 2013 ª2013 Elsevier Ltd All rights reservedpeak intensities from HNCO spectra of
saturated (based on Kd values described
below) eIF4E-bound 4E-BP2 to those of
free 4E-BP2. Peak intensities from resi-
dues not implicated in the interaction
(those at the extreme N and C termini of
4E-BP2) are relatively uniform while
some regions of 4E-BP2 undergo signifi-
cant decrease (Y34-D90) or increase
(T19-A28) in peak intensities upon bind-
ing. The overall decrease in peakintensities is attributed to the slower tumbling and regions of
4E-BP2 with 70% to 100% reductions in intensities are impli-
cated in a direct interaction with eIF4E. Although the peaks of
the canonical site are completely lost upon eIF4E interaction,
residues extending well beyond this region show significant
loss of intensity, providing strong evidence that the binding inter-
face is not restricted to the canonical binding site.
Importantly, this extended binding interface can be described
as a bipartitemode of interaction involving two segments,G40-
P66 and H74-D90, termed the canonical site and secondary
binding site, respectively. The rest of the protein maintains its
intrinsically disordered nature with some residues from the N ter-
minus to the canonical site showing increased peak intensity
relative to the free state. This increase in peak intensity is likely
due to the loss of transient long range contacts or conformational
exchange that only occur in the free but not in the bound state.
Figure S3 shows residue A23 in its free state (where it exchanges
between two broad peaks, A23 and A230) and bound state (one
sharper intense peak). As a result, these regions become more
flexible in the bound state, partially compensating the entropic
loss from other regions. Note that this dynamic bipartite interface
is likely highly similar for the complex of 4E-BP2 with cap-bound
eIF4E because nearly identical NMR spectra are observed in the
presence of cap (Figure S4), which is expected based on previ-
ous studies of 4E-BP1 (Fletcher et al., 1998).
To test ourmodel of a bipartite binding interface of 4E-BP2, we
performed site-specific mutagenesis of critical residues and
monitored binding. 1H-15N TROSY-HSQCs experiments were
performed at different temperatures to modulate the chemical
exchange regime of conformational fluctuations within the com-
plex in an attempt to observe additional bound state resonances.
Based on the HNCO-derived mapping of the 4E-BP2 interface
(Figure 3D) and the sequence conservation between 4E-BP2
isoforms from different organisms (Figure S5), we designed per-
turbing mutations in both the canonical and secondary binding
Figure 5. Interaction of 4E-BP2 Mutants
with eIF4E
1H-15N TROSY-HSQC spectra of 15N-labeled 4E-
BP2 mutants in the absence (red) and presence
(blue) of unlabeled eIF4E at 20C for YL (A), A5 (B),
D78–82 (C), and YL+A5 (D) mutants. Note the loss
of intensity for (A), (B), and (C) with minimal effect
upon binding for (D), demonstrating the significant
interaction of each separate component of the
bipartite interface.
See also Figures S6 and S7.
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Structure and Binding of 4E-BP2sites. In the first construct (YL), Y54 and L59 residues in the
54YXXXXLF60 canonical binding site were mutated to alanine,
while the second and third constructs involve either deleting
the 78IPGVT82 segment (D78–82) or converting it to alanines,
78AAAAA82 (A5). The goal of the final mutant was to completely
disrupt binding by combining Y54A/L59A with 78AAAAA82
(YL+A5). Figure 5 shows spectra of thesemutants in the absence
and presence of unlabeled eIF4E at 20C. Similar to wild-type,
eIF4E binding results in significant loss of peak intensity for res-
idues in the binding interface, while most peaks for residues at
the interface were not observed due to broadening at 5 and
20C (Figures S5 and 5, respectively). However, unlike wild-
type 4E-BP2, the broadened bound peaks of D78–82 and A5
mutants begin to sharpen and become visible as the tempera-
ture is increased to 35C (Figure S6). In contrast, similar temper-
ature-dependent measurements on the YL mutant did not reveal
extra bound peaks, indicative of less conformational exchange
in the bound state for the canonical site than the 78IPGVT82
segment. The observation of resonances for the canonical site
in these secondary binding site mutations provides strong evi-
dence that the broadening in the bound state of the wild-type
4E-BP2 is not dominated by the tc effect, which should be iden-
tical, but by dynamic exchange due to the bipartite binding
mechanism. The double mutant (YL+ A5) did not bind to eIF4E
(no spectral changes, Figure 5D), confirming that each of these
mutants disrupts their respective binding elements.
We used ITC to provide affinities and thermodynamic param-
eters, enthalpies and entropies, of interaction for each construct
(Figure S7; Table 1). The KD value for eIF4E binding to wild-type
4E-BP2 is 3.2 ± 0.6 nM while binding to A5, D78–82 and YL
mutants are 19.4 ± 2.0 nM, 18.9 ± 1.3 nM and 331 ± 65 nM,
respectively, reflecting significant contributions from both the
canonical and secondary binding sites (Table 1). The interac-
tion of the canonical binding region is dominated by enthalpy
(DH = 7.4 and 6.9 kcal/mol for A5 and D78–82, respectively),Structure 21, 2186–2196, December 3, 2013 ªwhile that of the secondary binding site is
driven by entropy (TDS = 7.5 kcal/mol).
Together with the temperature-depen-
dent measurements described above,
these data point to the 78IPGVT82
segment undergoing more conforma-
tional fluctuations within the bound state
than the canonical site. Interactions
involving both sites are synergistic, with
a low nanomolar KD, since isolated
canonical site peptides bind in themicromolar range while there is no detected binding for the
H74-E89 fragment (Paku et al., 2012). Binding is abrogated in
the (YL+ A5) mutant with both sites perturbed, supporting the
bipartite definition of the binding interface from NMR data.
Binding of 4E-BP2 to eIF4E Leads to Chemical Shift
Perturbations and Resonance Broadening of eIF4E
To assess the eIF4E:4E-BP2 interaction from the eIF4E perspec-
tive, unlabeled 4E-BP2 was titrated into 15N-labeled cap-free
eIF4E, and 1H-15N TROSY-HSQC spectra were recorded. Fig-
ure S8 shows eIF4E spectra in the presence and absence of
saturating amounts of 4E-BP2, demonstrating changes in chem-
ical shifts and peak intensities upon 4E-BP2 binding. These were
quantified and mapped onto the crystal structure of the
eIF4E:4E-BP2 peptide complex (Figures 6A and 6B). Residues
of eIF4E in the binding interface undergoing significant changes
in peak intensities are localized to three main regions: (1) N30-
W43, part of the N-terminal disordered region and strand b1,
(2) N59-D90, strand b2, helix a1 and loop L3, and (3) D125-
G151, helix a2 and loop L5. Chemical shift changes, sensitive
to both direct interaction and conformational changes due to
binding, were more extensive, involving residues distributed
throughout eIF4E. Interestingly, some of the largest chemical
shift changes occur around the cap-binding region including
R157 and K162, which interact with phosphates of the
m7GpppN cap. Other residues important in cap binding such
as W56 and W102 and residues A203-T211 in loop L9 (see Fig-
ure 1) also undergo significant chemical shift changes, illus-
trating allosteric communication between the 4E-BP and cap-
binding sites.While therewas no significant loss of peak intensity
(broadening) in the first 29 residues on the disordered N termi-
nus, significant chemical shift changes were observed starting
from N25. This indicates that, while the binding surface begins
at N30, residues N25-A29 undergo conformational changes
that cause these chemical shift changes. Previous eIF4E deletion2013 Elsevier Ltd All rights reserved 2191
Table 1. Thermodynamic Parameters for the Interaction of eIF4E
and WT and Mutant 4E-BP2
Kd (nM) DH (kcal/mol) TDS (kcal/mol) n
WT 3.20 ± 0.6 8.81 ± 0.08 2.61 1.04 ± 0.01
A5 19.4 ± 2.0 7.41 ± 0.06 2.94 1.02 ± 0.01
D78–82 18.9 ± 1.3 6.94 ± 0.04 3.43 0.94 ± 0.02
YL 331 ± 65 1.19 ± 0.07 7.49 1.05 ± 0.01
YL+A5 nb nb nb nb
See also Figure S7. nb, no binding.
Structure
Structure and Binding of 4E-BP2studies have shown that residuesM1-N25 do not have any effect
on the affinity of eIF4E for full-length 4E-BP2, while deleting res-
iduesM1-H33 enhances the affinity by approximately two orders
of magnitude (Abiko et al., 2007). Together, these data suggest
that residues in the region N25 to H33 may be forming transient
contacts to other parts of eIF4E inhibiting binding and that inter-
action with 4E-BP2 disrupts these contacts.
DISCUSSION
Although the physiologically important interaction between
eIF4E and 4E-BPs has been long studied, there have not been
detailed atomic-level structural studies of full-length 4E-BPs or
their interaction with cap-free eIF4E. Here, the assignment of
full-length 4E-BP2 enabled us to characterize its structural and
dynamic properties in the free state as well as investigate its
interaction with eIF4E. Whereas they lack stable secondary
and tertiary structural elements, many IDPs have transient sec-
ondary structure or structural contacts, which can play roles in
biological recognition (Fuxreiter et al., 2004; Mohan et al.,
2006). The SSP values and heteronuclear relaxation studies
indicate that 4E-BP2 contains significant transient structure
throughout the protein with a high helical propensity at the
canonical binding site. In the crystal structure of eIF4E in com-
plex with a 4E-BP2 peptide (Figure 1), this peptide adopts a fully
stabilized a helix flanked by extended structures (Fukuyo et al.,
2011). Thus, the fluctuating structure in free 4E-BP2 includes
conformations similar to those observed in the crystal structure
of the stabilized peptide complex. This pre-existing transient
structure may enhance binding to eIF4E by conformational
selection or by decreasing the entropic penalty of association
(Gsponer and Babu, 2009). Interestingly, a previous SAXS
envelop of full-length apo 4E-BP from Strongylocentrotus pur-
puratus suggests the presence of a stabilized central region, in
agreement with the high helical propensities in the middle of
the protein (Gosselin et al., 2011).
Interactions of IDPs range from full disorder-to-order transi-
tions to complete ‘‘fuzziness’’ where little or no structure is
induced upon binding (Fuxreiter and Tompa, 2012). Our data
show that 4E-BP2 interacts with eIF4E using a bipartite interface,
with both the canonical and secondary binding sites making sig-
nificant contributions to the energetics of binding, shifting the
micromolar binding of the canonical 4E-BP peptides to nanomo-
lar for the full-length protein. The loss of bound resonances
within the interaction interface likely originates from broadening
due to microsecond to millisecond conformational exchange
within the complex. The conformational exchange can be envi-2192 Structure 21, 2186–2196, December 3, 2013 ª2013 Elsevier Ltdsioned as different segments of this bipartite interface of
4E-BP2 coming on and off the surface of eIF4E, resulting in a
heterogeneous ensemble within the bound state. Perturbing
the binding interface by mutagenesis enables observation of
the bound peaks as the temperature is increased for the canon-
ical site (with D78-82 and A5 mutants) but not the secondary site
(with YL mutant; Figure S6). Because all these constructs have
similar molecular weights, the appearance of the bound peaks
forD78–82 and A5mutants suggests that conformational hetero-
geneity, rather than the high molecular weight of the complex, is
the dominant factor in broadening the wild-type or YL complex.
These data also suggest that, in the complex with wild-type 4E-
BP2, the secondary binding site is more dynamic than the
canonical site. The regions of 4E-BP2 outside the binding inter-
face maintain their intrinsically disordered nature, with ‘‘flanking
fuzziness’’ (Fuxreiter and Tompa, 2012) and T19-A28 even
more flexible in the bound state. Similar bipartite/multivalent
interfaces with complicated dynamic exchange properties
have been observed in recent studies of the disordered c-Myc
transactivation domain:Bin1 SH3 domain complex and yeast
Abp1p SH3 domain:peptide interactions (Andresen et al.,
2012; Stollar et al., 2012). While investigations of broadened
peaks exchanging in the microsecond to millisecond time scales
are becoming straightforward, only recently have NMR tech-
niques been developed for studying ‘‘invisible’’ peaks in slow
exchange with a visible peak (Vallurupalli et al., 2012). These
techniques will be valuable in probing the dynamic properties
and chemical shifts of full-length 4E-BPs in their bound states.
The effect of 4E-BP2 binding on cap-free eIF4E is of particular
interest given thatmost studies have been performed in the pres-
ence of cap analogs. While allosteric effects of 4E-BP1 and
eIF4G peptides on cap-free eIF4E have been studied (Siddiqui
et al., 2012; Volpon et al., 2006), allosteric changes upon binding
of full-length 4E-BPs have not been investigated. Our data show
that 4E-BP2 binding causes significant resonance broadening
for residues on the binding surface of cap-free eIF4E, as would
be expected for 4E-BP2 exchanging on and off of eIF4E. Further-
more, our data show widespread long-range allosteric effects,
especially around the cap-binding region, and showmore exten-
sive chemical shift changes throughout eIF4E upon the binding
of full-length 4E-BP2 than observed for the 4E-BP1 or eIF4G
peptides (residues 47–66). Binding of 4E-BPs and eIF4G frag-
ments or full-length proteins enhances the affinity of eIF4E for
the mRNA cap (Ptushkina et al., 1999). More interestingly, it
was observed that there is a direct correlation between the
lengths of 4E-BP or eIF4G fragment and their affinities for
eIF4E, which also affects allosteric enhancement for mRNA
cap binding (Friedland et al., 2005). Importantly, this extent of
chemical shift changes in eIF4E was not observed for binding
of full-length 4E-BP2 in the presence of an mRNA cap (Matsuo
et al., 1997). Taken together, these data suggest that the binding
of the full-length 4E-BPs induces conformational changes on
cap-free eIF4E that are more favorable for mRNA cap binding
than those occurring upon binding 4E-BP/eIF4G peptides,
thereby increasing the affinity of eIF4E for capped mRNA.
While 4E-BP2 interacts with part of the disordered N terminus
of eIF4E, there is no induction of folding upon binding for the
rest of the N terminus, allowing this disordered tail to maintain
its intrinsically dynamic nature. These data support a model inAll rights reserved
Figure 6. Chemical Shift and Peak Intensity Changes within Cap-Free eIF4E upon Binding of Unlabeled 4E-BP2 at 20C
The spectral changes observed in Figure S8 are mapped onto the eIF4E structure in various complexes. Chemical shift changes (Figures 6A, 6C, and 6E) are
mapped onto ribbon diagrams of eIF4E with those >50 Hz shown in blue while those <50 Hz are represented by a gradient of blue to white (0 Hz). Residues for
which no data were available are shown in gray. Peak intensity changes are mapped onto a surface representation of eIF4E (Figures 6B, 6D, and 6F) with changes
of 70%–100% shown in green and those <70% represented by a gradient of green to white (0%). (Figures 6A and 6B) eIF4E:4E-BP2 (red; PDB code 3AM7),
(Figures 6C and 6D) eIF4E:eIF4G (orange; PDB 1RF8) (Figures 6E and 6F) eIF4E:Cup (purple; PDB 4AXG). The cap present in these structures is shown in stick
diagram. See also Figure S8.
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Structure and Binding of 4E-BP2which the two proteins interact tightly but remain very dynamic
within the complex. This tightly bound yet highly dynamic
eIF4E:4E-BP complex facilitates the regulation of translation
initiation through posttranslational modifications such as phos-
phorylation by high frequency exposure of target sites to kinases
and other enzymes (Dennis et al., 2011; Gingras et al., 1999b).
Multisite phosphorylation of 4E-BPs is a hierarchical process
that ultimately leads to the combination of electrostatic repulsion
from the highly acidic dorsal surface of eIF4E (Gross et al., 2003;
Marcotrigiano et al., 1999) and the modulation of the propensity
of the canonical helical element within 4E-BPs to fold upon bind-
ing to eIF4E (Tait et al., 2010). Our dynamic model of the human
eIF4E:4E-BP2 interaction resembles the previously published
low-resolution model derived from SAXS data on 4E-BP from
S. purpuratus in which residues 25–88 interact with eIF4E
(Gosselin et al., 2011).
The data presented in this study provide insight into the
differences in binding mechanisms of 4E-BPs and eIF4G for
eIF4E, outside of the canonical binding regions containing the
YXXXXLF motifs of 4E-BPs and eIF4G, which are very similar.
Previous NMR binding studies of eIF4E with a 98-residue frag-
ment of yeast eIF4G (Gross et al., 2003) shows that eIF4G un-
dergoes a disorder-to-order transition and forms a right-handed
helical ring wrapping around the N terminus of eIF4E. Compared
to the eIF4E:eIF4G complex, our work shows that full-length 4E-
BP2 has overlapping, but distinct, binding surfaces on eIF4E
(Figures 6C and 6D). While the binding surface of eIF4G centers
around the partly folded N terminus of eIF4E, full-length 4E-BP2
interacts more extensively on the surface of eIF4E.
The bipartitemode of interactionwith eIF4E is not unique to the
4E-BPs. Biochemical and X-ray crystal studies of the eIF4E:Cup
interaction show a similar mechanismwhere two distinct binding
segments of Cup interact with different regions of eIF4E (Kinkelin
et al., 2012; Nelson et al., 2004). While the canonical binding site
of Cup interacts similarly with that of 4E-BP2, the interaction of
the noncanonical site of Cup is likely to be significantly different
from that of the secondary site of 4E-BP2. Superimposing theStructure 21, 2186–21structure of the eIF4E:4E-BP2 peptide complex with that of
the eIF4E:Cup complex shows that the interaction surface of
the non-canonical binding site of Cup does not overlay well
with that of the resonance broadening or chemical shift changes
caused by full-length 4E-BP2 binding (Figures 6E and 6F). While
the primary amino acid sequences of the canonical binding sites
of 4E-BP2 and Cup align quite well, this is not true for their sec-
ond sites (Figure S9); the crystal structure of the Cup complex as
well as the programAGADIR (Mun˜oz and Serrano, 1994) predicts
a helix propensity for the noncanonical site of Cup, while this is
not the case for the secondary site of 4E-BP2 (Figure S10). How-
ever, both complexes are likely to be highly dynamic considering
the fact that most of the residues between the canonical and
noncanonical binding sites of Cupwere not observed in the crys-
tal structure as a result of inherent flexibility or the limited prote-
olysis necessary to allow crystal formation.
Understanding and exploiting the multitude of molecular
mechanisms of eIF4E binding partners will be valuable for
developing effective therapeutics. Moerke and colleagues have
shown that, whereas the eIF4F inhibitor 4GI-1 can disrupt the
interaction of eIF4E with eIF4G, it enhances the interaction
with 4E-BP1 (Moerke et al., 2007). Binding of 4GI-1 has been
mapped to residues H37, V69, L131, and I138 of eIF4E, but these
represent a tiny fraction of the binding surface of 4E-BP2. The
eIF4E:4GI-1 interaction may enhance binding of 4E-BPs by
releasing a similar inhibitory effect on 4E-BP2 binding as deleting
residues 26–33 of the disordered N terminus (Abiko et al., 2007).
Results from our studies set the stage for further atomic level
characterization of full-length eIF4E:4E-BP complexes and ulti-
mately rational design of novel therapeutics that will selectively
target the eIF4G complex, but not the 4E-BP complexes.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Glutathione-S-transferase (GST) and small ubiquitin-like modifier (SUMO)
fusion constructs containing full-length cDNA for human 4E-BP2 and eIF4E96, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2193
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Structure and Binding of 4E-BP2(Gingras et al., 1999b) were expressed in BL21 codon plus cells. All mutants
were generated using QuikChange site-directed mutagenesis (Strategene).
Protein expression and purification of both unlabeled and uniformly 15N-
and/or 13C-labeled cap-free eIF4E and 4E-BP2 were performed using
standard affinity purification protocols from GE Healthcare and Invitrogen,
respectively.
NMR Spectroscopy and ITC Binding
All NMR experiments were performed on Varian INOVA 500, 600 and 800 MHz
spectrometers equipped with pulsed field gradient units and triple resonance
probes. The 600 MHz spectrometer was also equipped with a cryo probe.
NMR spectra were processed with the NMRPipe software package (Delaglio
et al., 1995) and analyzed using SPARKY (Goddard and Kneller, 2006). Back-
bone and side chain assignments of 4E-BP2 were obtained using a combina-
tion of standard triple resonance experiments and those specifically designed
for IDPs/proteins rich in prolines. Chemical shifts assignments were deposited
in the Biological Magnetic Resonance Bank (BMRB) database (accession
number 19114). The SSP program was used to calculate the secondary struc-
tural propensities (Marsh et al., 2006). 15N-relaxation experiments were per-
formed as previously described (Farrow et al., 1994; Palmer and Massi,
2006). For binding studies, protein samples were dialyzed for 16 hr in 4 l of
30 mM Na2HPO4, pH 6.0, 100 mM NaCl, 2 mM dithiothreitol, and 1 mM
EDTA. To form an eIF4E:4E-BP2 WT or mutant complex for NMR studies,
the proteins were mixed with 5 ml of 20 mM labeled component and the unla-
beled component was added in 2-fold excess. The mixture was incubated
at 7C for 1 hr before it was concentrated and loaded onto a Superdex
75 gel filltration column equilibrated with the same buffer. The fractions
containing the complex were pooled, concentrated, and then used to perform
the NMR experiments at 5C, 20C, or 35C using TROSY-HSQC experiments
(Pervushin et al., 1997). To test the effect of the mRNA cap on the structural
and binding properties of 4E-BP2, TROSY-HSQCs of the complex were
measured at 20C in the presence and absence of 1 mM 7-methylguanosine
50-diphosphate (Sigma-Aldrich). To quantitatively monitor the interaction,
binding experiments were performed on 180 mM 15N,13C-labeled free 4E-
BP2 with 250 mM unlabeled eIF4E. TROSY-HNCO experiments (Salzmann
et al., 1998) were performed on the free and complex samples that were
thenmixed to obtain 0.2, 0.6, and 1.4molar ratios. HNCO experiments, instead
of HSQCs, were used for the titration to obtain better chemical shift resolution.
Chemical shift changes, peak intensities and linewidths were then analyzed
using SPARKY. Similar analyses using TROSY-HSQCs were performed with
15N-labeled eIF4E and unlabeled 4E-BP2. ITC experiments were performed
using VP-ITC and iTC200 microcalorimeters (MicroCal) at 20C with the
sample cell containing 2–50 mM eIF4E and the syringe with 20–500 mM 4E-
BP2 wild-type or mutant. Runs were performed using 13–20 injections at an
interval of 120 s and each binding experiment was repeated twice. See the
Supplemental Experimental Procedures for a detailed description of the
materials and methods.
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